Search results
Results from the WOW.Com Content Network
A blue circle, the symbol for diabetes. High blood sugar levels, autoantibodies targeting insulin-producing cells. Type 1 diabetes ( T1D ), formerly known as juvenile diabetes, is an autoimmune disease that originates when cells that make insulin (beta cells) are destroyed by the immune system. [ 5] Insulin is a hormone required for the cells ...
AIDA is a freeware computer program that permits the interactive simulation of plasma insulin and blood glucose profiles for demonstration, teaching, self-learning, and research purposes. [ 1] Originally developed in 1991, [ 2] it has been updated and enhanced since, and made available without charge from 1996 on the World Wide Web. [ 3]
Endocrinology. Complications of diabetes are secondary diseases that are a result of elevated blood glucose levels that occur in diabetic patients. These complications can be divided into two types: acute and chronic. Acute complications are complications that develop rapidly and can be exemplified as diabetic ketoacidosis (DKA), hyperglycemic ...
Richard K. Bernstein. Richard K. Bernstein (born June 17, 1934) is a physician and an advocate for a low-carbohydrate diabetes diet to help achieve normal blood sugars for diabetics. Bernstein has type 1 diabetes. His private medical practice in Mamaroneck, New York is devoted solely to treating diabetes and prediabetes.
Type 1 diabetes, also known as juvenile diabetes, is a condition in which the body does not produce insulin, resulting in high levels of sugar in the bloodstream. [1] [2] Whereas type 2 diabetes is typically diagnosed in middle age and treated via diet, oral medication and/or insulin therapy, type 1 diabetes tends to be diagnosed earlier in life, and people with type 1 diabetes require insulin ...
The health benefits of green tea are well documented, including its potential to help prevent and manage Type 2 diabetes. Enjoying green tea hot or iced can become a delightful part of each day ...
Shadow Health is an educational software developer of learning environments termed "Digital Clinical Experiences™" (DCEs). Founded in Gainesville, Florida in 2011, [1] Shadow Health claims to offer web-based clinical learning environments for students and faculty in the fields of nursing and healthcare. As a learning management system, each ...
GLP-1 agonists were developed initially for type 2 diabetes. [5] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonist or SGLT2 inhibitor as a first line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart failure.